The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Methylphenidate Extended-Release
methylphenidate extended-release · METHYLPHENIDATE 8.6 mg/1 · Tablet, Orally Disintegrating · Oral · Neos Therapeutics, LP
NDC 62542-0100-31 · 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for methylphenidate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA205489
- TE code
- AB
- Approval date
- Jun 19, 2017
- Patents / exclusivity
- 12 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11166947 | Jan 25, 2038 |
| patent | 11166947 | Jan 25, 2038 |
| patent | 11166947 | Jan 25, 2038 |
| patent | 9089496 | Jun 28, 2032 |
| patent | 9089496 | Jun 28, 2032 |
| patent | 9072680 | Jun 28, 2032 |
| patent | 9089496 | Jun 28, 2032 |
| patent | 9072680 | Jun 28, 2032 |
| patent | 9072680 | Jun 28, 2032 |
| patent | 8840924 | Jun 5, 2026 |
| patent | 8840924 | Jun 5, 2026 |
| patent | 8840924 | Jun 5, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of methylphenidate extended-release (Tablet, Orally Disintegrating)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Neos Therapeutics, LP | METHYLPHENIDATE 17.3 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Neos Therapeutics, LP | METHYLPHENIDATE 25.9 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Neos Therapeutics, LP | METHYLPHENIDATE 8.6 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Methylphenidate Extended-Release — NDC 62542-0100-31," retrieved September 3, 2026, https://drugdashboards.com/drug/62542010031.
Free to cite with attribution — see how the data is put together.